News

This twice-a-year shot to prevent HIV could stop transmission — if people can get it
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
Should You Buy Gilead Stock At $110?
Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.
The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who ...
FOX 11 Los Angeles1d
FDA approves new twice-yearly HIV prevention shot. Here's how it works
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
The Independent15h
UNAIDS urges Gilead to cut price of new HIV prevention drug
The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The ...
Pharmaceutical Technology on MSN1d
Gilead Sciences’ Yeztugo receives approval from US FDA for HIV
This is a historic day in the decades-long fight against HIV. Yeztugo is one of the most important scientific breakthrou ...
STAT2d
Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access?
Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income ...
pharmaphorum2d
Gilead's twice-yearly PrEP drug is cleared by FDA
Gilead is now waiting for regulatory decisions on the twice-yearly PrEP in Europe and other markets, including South Africa ...
FDA approves first twice-yearly injection that prevents HIV infection
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.
Long-acting HIV prevention drug from Gilead wins FDA approval. Will it get to the people who need it?
The drug is groundbreaking, potentially eliminating the need for a long-sought-after HIV vaccine. In her own words: Anne ...
US FDA approves Gilead's twice-yearly injection for HIV prevention
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for ...